The long-term outcomes and histological transformation in class II lupus nephritis.
Conclusions: Daily steroid monotherapy may be an appropriate first-line treatment for class II LN that presents with subnephrotic range proteinuria and normal kidney function. Patients with acute kidney injury and/or nephrotic range proteinuria may warrant more aggressive immunosuppressive regimens.
PMID: 30284580 [PubMed - in process]
Source: Saudi Medical Journal - Category: Middle East Health Tags: Saudi Med J Source Type: research
More News: Lupus | Middle East Health | Nephritis | Proteinuria | Saudi Arabia Health | Study | Urology & Nephrology